Display options
Share it on

Data Brief. 2016 Feb 24;7:349-53. doi: 10.1016/j.dib.2016.02.031. eCollection 2016 Jun.

MS-analysis of SILAC-labeled MYC-driven B lymphoma cells overexpressing miR-17-19b.

Data in brief

Marija Mihailovich, Tiziana Bonaldi

Affiliations

  1. Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.

PMID: 26977435 PMCID: PMC4781929 DOI: 10.1016/j.dib.2016.02.031

Abstract

Micro RNAs (miRNAs) are small non-coding RNAs, which dampen gene expression by repressing translation and/or inducing degradation of target-mRNAs. Although the role of miR-17-19b (a truncated version of miR-17-92 cluster) is well documented in MYC-driven B cell lymphomagenesis, little is known about the function of the cluster in the maintenance of full-blown lymphomas. We employed SILAC-based quantitative proteomics to identify miR-17-19b targets upon a mild overexpression of the cluster in B cell lymphomas, established from λ-MYC transgenic mice. The proteomics data described in detail in this study, whose follow up analysis with MaxQuant algorithm is part of the recent publication (Mihailovich et al., 2015) [1], are deposited to the ProteomeXchange Consortium via the PRIDE partner repository, with the accession code PRIDE: PXD002810.

Keywords: B cell lymphoma; MYC; Mass spectrometry; MiR-17-92; MiRNA targets; Quantitative proteomics; SILAC

References

  1. Proteomics. 2008 Dec;8(23-24):4862-72 - PubMed
  2. Nat Commun. 2015 Nov 10;6:8725 - PubMed
  3. Nat Protoc. 2006;1(6):2856-60 - PubMed
  4. Nat Protoc. 2007;2(8):1896-906 - PubMed
  5. Mol Cell Proteomics. 2002 May;1(5):376-86 - PubMed
  6. J Exp Med. 2000 Oct 16;192(8):1183-90 - PubMed

Publication Types